Literature DB >> 30282027

Cell Aggregation Culture Induces Functional Differentiation of Induced Hepatocyte-like Cells through Activation of Hippo Signaling.

Junpei Yamamoto1, Miyako Udono1, Shizuka Miura1, Sayaka Sekiya1, Atsushi Suzuki2.   

Abstract

Recent progress in direct lineage reprogramming has enabled the generation of induced hepatocyte-like (iHep) cells and revealed their potential as an alternative to hepatocytes for medical applications. However, the hepatic functions of iHep cells are insufficient compared with those of primary hepatocytes. Here, we show that cell-aggregate formation can rapidly induce growth arrest and hepatic maturation of iHep cells through activation of Hippo signaling. During formation of iHep cell aggregates, Yap inactivation is induced by actin reorganization and intercellular adhesion, leading to upregulation of Hnf1α expression in the absence of the Yap/Tead/Chd4 transcriptional repressor unit. Hnf1α then acts as a central transcription factor that regulates liver-enriched gene expression in iHep cell aggregates and induces functional differentiation of iHep cells. Moreover, iHep cell aggregates efficiently reconstitute injured liver tissues and support hepatic function after transplantation. Thus, iHep cell aggregates may provide insights into basic research and potential therapies for liver diseases.
Copyright © 2018 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Hippo signaling; cell aggregate; direct reprogramming; hepatocyte; iHep cell; transcription factor; transplantation

Year:  2018        PMID: 30282027     DOI: 10.1016/j.celrep.2018.09.010

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  8 in total

Review 1.  Organoid transplant approaches for the liver.

Authors:  Hasan Al Reza; Ryo Okabe; Takanori Takebe
Journal:  Transpl Int       Date:  2021-11       Impact factor: 3.782

2.  Conversion of mesenchymal stem cells into a canine hepatocyte-like cells by Foxa1 and Hnf4a.

Authors:  Suguru Nitta; Yuto Kusakari; Yoko Yamada; Takeaki Kubo; Sakurako Neo; Hirotaka Igarashi; Masaharu Hisasue
Journal:  Regen Ther       Date:  2020-02-20       Impact factor: 3.419

3.  Robust expansion and functional maturation of human hepatoblasts by chemical strategy.

Authors:  Tingcai Pan; Jiawang Tao; Yan Chen; Jiaye Zhang; Anteneh Getachew; Yuanqi Zhuang; Ning Wang; Yingying Xu; Shenglin Tan; Ji Fang; Fan Yang; Xianhua Lin; Kai You; Yi Gao; Yin-Xiong Li
Journal:  Stem Cell Res Ther       Date:  2021-02-25       Impact factor: 6.832

4.  Three-dimensional spheroid culture of canine hepatocyte-like cells derived from bone marrow mesenchymal stem cells.

Authors:  Suguru Nitta; Masaharu Hisasue; Yu Horiguchi; Yoko Yamada; Kaoruko Kikuchi; Takeaki Kubo; Hirotaka Igarashi; Sakurako Neo
Journal:  Regen Ther       Date:  2020-10-22       Impact factor: 3.419

5.  Induced Endothelial Cell-Integrated Liver Assembloids Promote Hepatic Maturation and Therapeutic Effect on Cholestatic Liver Fibrosis.

Authors:  Donggyu Nam; Myung Rae Park; Hyunah Lee; Sung Chul Bae; Daniela Gerovska; Marcos J Araúzo-Bravo; Holm Zaehres; Hans R Schöler; Jeong Beom Kim
Journal:  Cells       Date:  2022-07-19       Impact factor: 7.666

6.  The stemness of hepatocytes is maintained by high levels of lipopolysaccharide via YAP1 activation.

Authors:  Changchun Shao; Xue Yang; Yingying Jing; Xiaojuan Hou; Yihua Huang; Chen Zong; Lu Gao; Wenting Liu; Jinghua Jiang; Fei Ye; Junxia Shi; Qiudong Zhao; Rong Li; Xiaoren Zhang; Lixin Wei
Journal:  Stem Cell Res Ther       Date:  2021-06-10       Impact factor: 6.832

7.  Intact extracellular matrix component promotes maintenance of liver-specific functions and larger aggregates formation of primary rat hepatocytes.

Authors:  Ronald P Bual; Hiroyuki Ijima
Journal:  Regen Ther       Date:  2019-09-17       Impact factor: 3.419

8.  Progress in human liver organoids.

Authors:  Lulu Sun; Lijian Hui
Journal:  J Mol Cell Biol       Date:  2020-08-01       Impact factor: 6.216

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.